The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
P/E ratio for Amgen (AMGN)
P/E ratio as of July 2025 (TTM): 27.0
According to Amgen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 26.99. At the end of 2024 the company had a P/E ratio of 34.2.
P/E ratio history for Amgen from 2001 to 2025
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | 34.2 | 49.16% |
| 2023 | 22.9 | 6.35% |
| 2022 | 21.6 | -0.7% |
| 2021 | 21.7 | 17.02% |
| 2020 | 18.6 | -0.31% |
| 2019 | 18.6 | 21.35% |
| 2018 | 15.3 | -76.8% |
| 2017 | 66.1 | 366.71% |
| 2016 | 14.2 | -20.05% |
| 2015 | 17.7 | -24.46% |
| 2014 | 23.5 | 38.6% |
| 2013 | 16.9 | 9.96% |
| 2012 | 15.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 18.3 | -32.35% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 17.5 | -35.13% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 24.5 | -9.31% | 🇬🇧 UK |
 Gilead Sciences GILD | 23.4 | -13.38% | 🇺🇸 USA |
 Biogen BIIB | 13.1 | -51.55% | 🇺🇸 USA |
 AbbVie ABBV | 80.3 | 197.47% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 17.2 | -36.25% | 🇺🇸 USA |
 Illumina ILMN | -16.7 | -161.73% | 🇺🇸 USA |
 Eli Lilly LLY | 63.2 | 134.09% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.